Zivo Bioscience, Inc.

8 patents currently held · Updated Nov 15, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Health Enhancement Products, Inc. (to 2017)

Ending by 2030

Feb 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due May 7, 2027
The maintenance fee for Nutritional support for animals via administration of an algal derived supplement (US 11,806,375) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 8,791,060	Composition and use of phyto-percolate for treatment of disease In force Term ends Feb 19, 2027 · From the USPTO record	In force	Term ends Feb 19, 2027	From the USPTO record
US 10,842,179	Agents and mechanisms for treating hypercholesterolemia In force Term ends Feb 22, 2032 · From the USPTO record	In force	Term ends Feb 22, 2032	From the USPTO record
US 10,765,732	Compounds and methods for affecting cytokines In force Ends no later than Jun 13, 2033 · From the USPTO record	In force	Ends no later than Jun 13, 2033	From the USPTO record
US 10,232,028	Compounds and Methods for Affecting Cytokines In force Ends no later than Jun 13, 2034 · Medium confidence	In force	Ends no later than Jun 13, 2034	Medium confidence
US 11,065,287	Methods of modulating immune and inflammatory responses via administration of an algal biomass In force Term ends Feb 16, 2036 · From the USPTO record	In force	Term ends Feb 16, 2036	From the USPTO record
US 11,806,375	Nutritional support for animals via administration of an algal derived supplement In force Term ends Jan 12, 2039 · From the USPTO record	In force	Term ends Jan 12, 2039	From the USPTO record
US 12,721,889	Immune Priming to Accelerate/Enhance Immune Response Through Administration of Natural Immune Modulator In force Ends no later than Jun 25, 2041 · Medium confidence	In force	Ends no later than Jun 25, 2041	Medium confidence
US 12,599,657	Enhancement of Vaccine Efficacy via Biomass And/Or Related Material in Animal Drink and Feed In force Ends no later than Sep 29, 2044 · Medium confidence	In force	Ends no later than Sep 29, 2044	Medium confidence

Also on record, not counted in the 8: 1 patent in force now held by others · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 6 abandoned · 4 no status recorded

List them